The Israeli energy-device maker is exploring a potential acquisition, reflecting ongoing PE and strategic buyer interest in aesthetic-device platforms.
InMode announced receipt of an unsolicited acquisition proposal, confirming that a buyer—identity undisclosed—has expressed interest in acquiring the Israeli energy-device company. InMode manufactures RF microneedling, fractional RF, and other modalities under brands including Morpheus8 and EvoluTION, and has built significant market share in the U.S. aesthetic and surgical markets.
The proposal underscores ongoing appetite among PE firms and strategic buyers (device roll-ups, larger medtech companies) to consolidate aesthetic-device platforms. InMode's profitability, recurring revenue model (consumable tips and handpieces), and installed base make it an attractive target. The company's board is evaluating the proposal; no deal is certain.
Unsolicited proposal signals PE and strategic buyer appetite for consolidated device platforms.
For practices using InMode devices, a change of control could affect pricing, support, and product-development roadmap. Historically, PE-backed consolidations have led to price increases and tighter rebate terms as acquirers seek margin expansion. Monitor developments closely.
Source: original report ↗
Free alerts Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
